Bluejay Diagnostics Inc (BJDX)

$1.45 +0.04 (2.84%)
Market Cap 2.17M
Revenue (ttm) 0.00
Net Income (ttm) -7.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 83,500
Avg Vol 2,122,372
Day's Range N/A - N/A
Shares Out 1.49M
Stochastic %K 63%
Beta 0.48
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the compa...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
Niconiconee
Niconiconee Sep. 3 at 10:14 PM
$BJDX well well 👀
0 · Reply
Mister___B
Mister___B Sep. 3 at 8:02 PM
$BJDX 👀
0 · Reply
_Sensei_
_Sensei_ Sep. 3 at 7:32 PM
$BJDX looking primed
1 · Reply
stockpicks333
stockpicks333 Aug. 31 at 11:14 AM
$HIPP.X $ZBCN.X $MOG.X $BJDX Money coming money coming!
0 · Reply
stockpicks333
stockpicks333 Aug. 29 at 4:59 PM
$BJDX Waiting game
0 · Reply
Mister___B
Mister___B Aug. 29 at 11:06 AM
$BJDX where my pop
0 · Reply
stockpicks333
stockpicks333 Aug. 28 at 7:52 PM
$BJDX $LXEH .
0 · Reply
stockpicks333
stockpicks333 Aug. 28 at 2:17 PM
$BJDX selling here is like pissing yourself
0 · Reply
stockpicks333
stockpicks333 Aug. 26 at 12:58 PM
$BJDX Undervalued
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 25 at 8:48 PM
$BJDX update pending a bit busy for ow
0 · Reply
Latest News on BJDX
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 4 weeks ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 3 months ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 5 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 5 months ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 10 months ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 1 year ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 1 year ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 1 year ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 1 year ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 1 year ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 1 year ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 2 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 2 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Sep 8, 2022, 9:33 AM EDT - 3 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

BSGM STSS

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Why Bluejay Diagnostics Shares Are Surging Higher Today

Jun 9, 2022, 10:19 AM EDT - 3 years ago

Why Bluejay Diagnostics Shares Are Surging Higher Today

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Niconiconee
Niconiconee Sep. 3 at 10:14 PM
$BJDX well well 👀
0 · Reply
Mister___B
Mister___B Sep. 3 at 8:02 PM
$BJDX 👀
0 · Reply
_Sensei_
_Sensei_ Sep. 3 at 7:32 PM
$BJDX looking primed
1 · Reply
stockpicks333
stockpicks333 Aug. 31 at 11:14 AM
$HIPP.X $ZBCN.X $MOG.X $BJDX Money coming money coming!
0 · Reply
stockpicks333
stockpicks333 Aug. 29 at 4:59 PM
$BJDX Waiting game
0 · Reply
Mister___B
Mister___B Aug. 29 at 11:06 AM
$BJDX where my pop
0 · Reply
stockpicks333
stockpicks333 Aug. 28 at 7:52 PM
$BJDX $LXEH .
0 · Reply
stockpicks333
stockpicks333 Aug. 28 at 2:17 PM
$BJDX selling here is like pissing yourself
0 · Reply
stockpicks333
stockpicks333 Aug. 26 at 12:58 PM
$BJDX Undervalued
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 25 at 8:48 PM
$BJDX update pending a bit busy for ow
0 · Reply
GDog877
GDog877 Aug. 25 at 6:45 PM
$BJDX PERFECT exit point...
1 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 6:42 PM
$BJDX $1.60 nano float 1m. is about to EXPLODE huge like my other calls $INHD my call at $2.50 hit $6.24 $THAR my call at $1.38 hit $9.08
0 · Reply
stockpicks333
stockpicks333 Aug. 25 at 5:34 PM
$BJDX I take it here
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 5:24 PM
$BJDX $INHD $THAR
0 · Reply
ExplosiveGainz
ExplosiveGainz Aug. 25 at 5:19 PM
$BJDX 3$ pt full position here with a SL
0 · Reply
CCat07
CCat07 Aug. 25 at 5:15 PM
$BJDX someone smart just loaded 10k 🤑
0 · Reply
CCat07
CCat07 Aug. 25 at 5:06 PM
$BJDX is poised for a similar move to $INHD tiny float and great entry
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 4:53 PM
$BJDX $1.60 nano float 1m. can explode huge like my other calls $INHD my call at $2.50 hit $4.75 $THAR my call at $1.38 hit $9.08
3 · Reply
SergeMann
SergeMann Aug. 25 at 4:52 PM
$BJDX 🫡
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 4:48 PM
$BJDX SHORT SQUEEZE like $INHD ww
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 4:42 PM
$BJDX $2 next leg. nano float 1m. new $INHD my call at $2.50 hit $4.75
1 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Aug. 25 at 4:39 PM
$BJDX $2 break then boom boom like $THAR my call at $1.38 hit $9.08
0 · Reply